Cargando…

Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study

OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xin-liang, Zhou, Ya-ya, Fu, Wei, Xue, Yu-e, Liang, Meng-yuan, Yang, Bo-han, Ma, Wan-li, Zhou, Qiong, Chen, Long, Zhang, Jian-chu, Wang, Xiao-rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Huazhong University of Science and Technology 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436017/ https://www.ncbi.nlm.nih.gov/pubmed/34515914 http://dx.doi.org/10.1007/s11596-021-2434-y

Ejemplares similares

Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
por: Li, Hailong, et al.
Publicado: (2021)

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

A trial of arbidol hydrochloride in adults with COVID-19
por: Zhao, Jingya, et al.
Publicado: (2022)

Prolonged Viral Shedding in Three Young Adult Cases of COVID-19
por: Dong, Wen-Yi, et al.
Publicado: (2022)

Prolonged viral shedding in an immunocompetent patient with COVID-19
por: McKie, Anthony Michael, et al.
Publicado: (2020)

Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding
por: Wu, Yingping, et al.
Publicado: (2021)

COVID‐19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies
por: Yousaf, Muhammad, et al.
Publicado: (2021)

Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study
por: Zhang, Jin-nong, et al.
Publicado: (2020)

Factors associated with prolonged viral RNA shedding in patients with COVID-19
por: Xu, Kaijin, et al.
Publicado: (2020)

The Antiviral Drug Arbidol Inhibits Zika Virus
por: Fink, Susan L., et al.
Publicado: (2018)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Arbidol: The current demand, strategies, and antiviral mechanisms
por: Kang, Yue, et al.
Publicado: (2023)

Prolonged viral shedding and antibody persistence in patients with COVID-19
por: Fotouhi, Fatemeh, et al.
Publicado: (2021)

Case of Prolonged Viral Shedding: Chronic, Intermittan COVID-19?
por: Serez Kaya, Bilkay, et al.
Publicado: (2022)

Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo
por: Zhong, Qiong, et al.
Publicado: (2009)

Consult the Doctor
Publicado: (1921)

Real-world experience of arbidol for Omicron variant of SARS-CoV-2
por: Zhao, Jingya, et al.
Publicado: (2023)

Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients
por: Ogimi, Chikara, et al.
Publicado: (2018)

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
por: Yang, Chunguang, et al.
Publicado: (2020)

Beneficial effect of Arbidol in the management of COVID-19 infection
por: Jie, Xiong, et al.
Publicado: (2021)

Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
por: Xing, Yu-Han, et al.
Publicado: (2020)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

Case Report: Prolonged Viral Shedding in Six COVID-19 Patients
por: Alsaud, Arwa E., et al.
Publicado: (2021)

Multiple drugs: Diarrhoea and prolonged viral shedding: 2 case reports
Publicado: (2020)

Prolonged SARS-CoV2 Viral Shedding in an Elderly Patient
por: Jariwal, Roopam, et al.
Publicado: (2021)

Antineoplastics: Prolonged COVID-19 viral shedding: 3 case reports
Publicado: (2021)

Multiple drugs: Prolonged COVID-19 viral shedding: case report
Publicado: (2021)

Antineoplastics: Prolonged viral shedding of COVID-19 pneumonia : case report
Publicado: (2021)

278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2
por: Tarabay, Jessica, et al.
Publicado: (2021)

Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study
por: Feng, Zhichao, et al.
Publicado: (2020)

Glycomic Analysis Reveals That Sialyltransferase Inhibition Is Involved in the Antiviral Effects of Arbidol
por: Kang, Yue, et al.
Publicado: (2022)

Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)
por: Christophe, Véronique, et al.
Publicado: (2014)

Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
por: Zhu, Zhen, et al.
Publicado: (2020)

Synthesis and biological activity of water-soluble polymer complexes of arbidol
por: Eropkin, M. Yu., et al.
Publicado: (2010)

Efficacy of arbidol in COVID-19 patients: A retrospective study
por: Wei, Shuo, et al.
Publicado: (2021)

Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients
por: Gao, Chun, et al.
Publicado: (2020)

Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection
por: Bongiovanni, Marco, et al.
Publicado: (2021)

Prolonged viral shedding of SARS-CoV-2 in patients with acute leukemia
por: Altamirano-Molina, Milagros, et al.
Publicado: (2022)

Prolonged viral shedding from noninfectious individuals confounds wastewater-based epidemiology
por: Phan, Tin, et al.
Publicado: (2023)

Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol
por: Teissier, Elodie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kp0tvqb9ulc069m5als63r7ss3